- Home
- VCEL vs EAD Comparison
VCEL vs EAD Comparison
Compare VCEL & EAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VCEL | EAD |
|---|---|---|
| Founded | 1989 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 407.1M |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | VCEL | EAD |
|---|---|---|
| Price | $33.96 | $6.73 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $58.50 | N/A |
| AVG Volume (30 Days) | ★ 424.1K | 146.4K |
| Earning Date | 05-18-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.91% |
| EPS Growth | ★ 60.00 | N/A |
| EPS | ★ 0.32 | N/A |
| Revenue | ★ $276,259,000.00 | N/A |
| Revenue This Year | $20.11 | N/A |
| Revenue Next Year | $19.40 | N/A |
| P/E Ratio | $106.22 | ★ N/A |
| Revenue Growth | ★ 16.45 | N/A |
| 52 Week Low | $29.24 | $5.89 |
| 52 Week High | $49.38 | $7.18 |
Technical Indicators
Market Signals| Indicator | VCEL | EAD |
|---|---|---|
| Relative Strength Index (RSI) | 38.96 | 31.13 |
| Support Level | $30.17 | $6.68 |
| Resistance Level | $38.48 | $6.92 |
| Average True Range (ATR) | 1.66 | 0.04 |
| MACD | -0.29 | -0.01 |
| Stochastic Oscillator | 9.13 | 3.33 |
Price Performance
Historical ComparisonAbout VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
About EAD Allspring Income Opportunities Fund
Allspring Income Opportunities Fund is a diversified closed-end management investment company. Its products and services are mutual funds, closed-end funds, managed accounts services, and variable trust funds. The fund's objective is a high level of current income and capital appreciation. Its portfolio of investments is Commercial services, healthcare services, Food, Pharmaceuticals, Energy, Oil & gas, Pipelines, Diversified financial services, and Others.